痰液纳米颗粒扩散作为评估COPD严重程度的生物物理工具
研究探讨COPD自咳痰中黏液网格结构(以纳米颗粒扩散量化)与疾病严重程度的关系。采用多颗粒追踪测量不同尺寸黏液惰性纳米颗粒(MIP)的均方位移(MSD),分析33份COPD或非COPD样本。发现100 nm MIP可区分COPD痰液微结构特征,MSD与肺功能呈负相关,提示痰液微结构或为COPD进展和严重程度的新风险因素。
要点
- 100 nm黏液惰性纳米颗粒可区分COPD痰液微结构特征。
- 重症COPD患者痰液中纳米颗粒运动受限更明显,提示黏液网格更紧密。
- 痰液MSD值与肺功能呈负相关,或反映疾病严重程度。
核心结论
- COPD痰液微结构(网格紧密程度)与疾病严重程度相关,或为COPD进展的新风险因素。
研究设计与样本
- 研究采用多颗粒追踪技术测量不同尺寸黏液惰性纳米颗粒在自咳痰中的均方位移,共分析33份来自COPD或非COPD个体的样本。
主要发现
- 100 nm MIP可区分COPD痰液的微结构特征。
- 重症COPD患者痰液中MIP运动更受限,提示黏液网格尺寸更紧密。
- MSD值与肺功能呈负相关。
临床怎么用
- 痰液纳米颗粒扩散分析或可作为评估COPD严重程度和进展风险的生物物理工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Perturbations in airway mucus properties contribute to lung function decline in patients with chronic obstructive pulmonary disease (COPD). While alterations in bulk mucus rheology have been widely explored, microscopic mucus properties that directly impact on the dynamics of microorganisms and immune cells in the COPD lungs are yet to be investigated.We hypothesised that a tightened mesh structure of spontaneously expectorated mucus (i.e. sputum) would contribute to increased COPD disease severity. Here, we investigated whether the mesh size of COPD sputum, quantified by muco-inert nanoparticle (MIP) diffusion, correlated with sputum composition and lung function measurements.The microstructure of COPD sputum was assessed based on the mean squared displacement (MSD) of variously sized MIPs measured by multiple particle tracking. MSD values were correlated with sputum composition and spirometry. In total, 33 samples collected from COPD or non-COPD individuals were analysed.We found that 100 nm MIPs differentiated microstructural features of COPD sputum. The mobility of MIPs was more hindered in sputum samples from patients with severe COPD, suggesting a tighter mucus mesh size. Specifically, MSD values inversely correlated with lung function.These findings suggest that sputum microstructure may serve as a novel risk factor for COPD progression and severity.
引用
- Chisholm JF, Shenoy SK, Shade JK, et al. Nanoparticle diffusion in spontaneously expectorated sputum as a biophysical tool to probe disease severity in COPD. Eur Respir J. 2019. PMID: 31164433. doi:10.1183/13993003.00088-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。